For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Patients with Cushing's disease treated with bilateral adrenalectomy are also at risk for Nelson's syndrome (corticotroph tumor progression) which occurs in up to 50% of the patients. [1, 11, 19 ...

Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient has been successfully dosed in its ongoing Phase 2 ...

The company's lead programs, ST-002 for Cushing's Syndrome and ST-003 for primary sclerosing cholangitis, have demonstrated strong preclinical and early clinical results, with favorable safety ...

In patients who transitioned from injected SRLs to once-daily oral PALSONIFY, mean insulin-like growth factor 1 (IGF-1) levels remained stable with IGF-1 (mean ± SE) of 0.93 ± 0.22 at OLE baseline and ...

Sterotherapeutics Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating ST-002 for Cushing's Syndrome By Sterotherapeutics LLC Jun 24, 2025 Updated Jun 24, 2025 ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years. On June ...

Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient has been successfully dosed in its ongoing Phase 2 clinical ...

Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...

Ben Askren gave an update on his health a month after the MMA fighter was hospitalized with a severe case of pneumonia, ...